WENTWORTH KORY JAMES

PrivateCIK: 1725663

WENTWORTH KORY JAMES (Chief Financial Officer) received a stock award from ENTRADA THERAPEUTICS, INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award
InsiderWENTWORTH KORY JAMESCIK 1725663
Officer· Chief Financial Officer
Since Oct 2021
+102.55K
Net shares
Net buyer
$101.4K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
111.20K acquired · 8.65K disposed
Non-Derivative Transactions3

Common Stock

Direct
A · Award

Shares

+44.60K

Price / share

Trade value

% of position

40.5%
3/1/2026
110.03K154.63K

Common Stock

Direct
F · Tax Withholding

Shares

2.94K

Price / share

$11.66

Trade value

$34.26K

% of position

1.9%
3/2/2026
154.63K151.69K

Common Stock

Direct
F · Tax Withholding

Shares

5.71K

Price / share

$11.76

Trade value

$67.15K

% of position

3.8%
3/3/2026
151.69K145.97K
Total

Net shares

+35.95K

Net value

-$101.42K

Derivative Transactions1

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

66.60K shares

Shares

+66.60K

Strike price

11.93

Held after

66.60K

Exercisable

3/1/2026
WENTWORTH KORY JAMES — Insider Transaction (Form 4) Filed Mar 3, 2026 | Finecho